sc 58125 has been researched along with Laryngeal Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chang, Q; Ding, J; Gong, S | 1 |
1 other study(ies) available for sc 58125 and Laryngeal Neoplasms
Article | Year |
---|---|
Inhibitory effects of Celecoxib and Sc-58125 on proliferation of human carcinoma of larynx Hep-2 in vitro.
Topics: Antineoplastic Agents; Apoptosis; Celecoxib; Cell Proliferation; Cyclooxygenase 2 Inhibitors; Dose-Response Relationship, Drug; Humans; Laryngeal Neoplasms; Pyrazoles; Sulfonamides; Tumor Cells, Cultured | 2005 |